Alnylam Pharmaceuticals
ALNY
#499
Rank
$48.88 B
Marketcap
$370.00
Share price
1.24%
Change (1 day)
38.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company